Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators

Keyphrases

• Estrogen Receptor 100%
• Transcriptional Regulation 100%
• Receptor Targets 100%
• Fallopian Tube 100%
• Selective Estrogen Receptor Modulators 100%
• Tube Cell 100%
• Estrogen 60%
• Estradiol 60%
• High-grade Serous Ovarian Cancer (HGSOC) 60%
• Gene Targeting 40%
• Cellular Migration 40%
• RNA Sequencing (RNA-seq) 40%
• Ovarian Cancer 40%
• Progesterone Receptor 40%
• 4-hydroxytamoxifen 40%
• Ovarian Epithelial Cancer 40%
• Fallopian Tube Epithelium 40%
• Tumor 20%
• Specific Genes 20%
• Receptor Expression 20%
• Cell Proliferation 20%
• Therapeutic Potential 20%
• Estrogen Receptor Status 20%
• Estrogen Receptor Antagonist 20%
• Proliferation Assay 20%
• Signal Process 20%
• Oviduct 20%
• Calcium Signaling 20%
• Estrogen-responsive 20%
• % Response 20%
• Ovarian Cancer Cells 20%
• Migration Assay 20%
• Low Response 20%
• Raloxifene 20%
• Hormone Replacement Therapy 20%
• Steroid Hormone Signalling 20%
• Tissue-specific Response 20%
• Estrogen Receptor Signaling 20%
• Anti-apoptosis 20%
• Ovarian Cancer Risk 20%
• Antagonistic Activity 20%
• Receptor Status 20%
• Protein Induction 20%
• OVCAR-3 20%
• ER Receptors 20%

Medicine and Dentistry

• Ovarian Cancer 100%
• Estrogen Receptor 100%
• Selective Estrogen Receptor Modulator 100%
• Fallopian Tube 100%
• Diethylstilbestrol 60%
• Cell Migration 40%
• Receptor Expression 40%
• Afimoxifene 40%
• Progesterone Receptor 40%
• Fallopian Tube Epithelium 40%
• Neoplasm 20%
• Epithelial Cell 20%
• Programmed Cell Death 20%
• Receptor 20%
• Cell Proliferation 20%
• Calcium Signaling 20%
• RNA Sequencing 20%
• Cancer Risk 20%
• Hormone Substitution 20%
• Raloxifene 20%
• Ovarian Cancer Cell Line 20%
• Protein Induction 20%
• Estrogen Receptor Antagonist 20%
• Cell Membrane Potential 20%
• Messenger RNA 20%
• Oviduct 20%